Moody's reviews PharMEDium's ratings for upgrade
Moodys.com (press release) (subscription)-5 hours ago
The B3 CFR (currently under review for upgrade) incorporates the business risk arising from PharMEDium's singular focus on the sterile
Human Medications, Human Drugs, Animal Medications, Animal Drugs, Pharmacy law, Pharmaceutical law, Compounding law, Sterile and Non Sterile Compounding 797 Compliance, Veterinary law, Veterinary Compounding Law; Health Care; Awareness of all Types of Compounding Issues; Pharmacy Benefit Managers (PBMs), Outsourcing Facilities Food and Drug Administration and Compliance Issues
No comments:
Post a Comment